Uji Efektifitas Antiinflamasi Sediaan Ko-Amorf Ketoprofen-L-Arginin Dengan Metode Paw Edema Pada Tikus Wistar Jantan
Sari
Inflamasi merupakan suatu bentuk respon terhadap kerusakan jaringan pada tubuh. Ketoprofen merupakan golongan senyawa antiinflamasi non-steroid (NSAID) yang memiliki kelarutan yang rendah dalam air. Formulasi ko-amorf ketoprofen dan l-arginin dengan perbandingan molar 1:1 mampu memperbaiki kelarutan dan disolusi ketoprofen. Ko-amorf ketoprofen-l-arginin diuji aktifitasnya dengan metode Paw Edema. Sediaan diujikan kepada tikus jantan galur Wistar dengan bobot sekitar 200 g. Penelitian dilakukan terhadap 15 tikus yang dibagi ke dalam tiga kelompok perlakuan; suspensi CMC-Na 0,5%; suspensi ketoprofen murni dengan dosis 3,6 mg/200 gBB; suspensi ko-amorf ketoprofen-l-arginin 5,3 mg Kg/200 gBB (setara 3,6 mg/200 gBB ketoprofen murni). Pemberian obat diberikan secara per oral, 30 menit kemudian diikuti induksi karagenan 1% secara intraplantar untuk memicu edema. Pengukuran volume edema dilakukan setiap 60 menit selama 360 menit menggunakan alat plethysmometer. Data volume udem diubah menjadi persentase rata-rata volume udem dianalisis secara statistik menggunakan SPSS. Hasil penelitian menunjukkan suspensi ko-amorf ketoprofen – L-arginin 1:1 mampu menurunkan volume edema pada kaki tikus Wistar jantan dibandingkan suspensi ketoprofen murni dan CMC-Na 0,5%.
Kata Kunci
Teks Lengkap:
PDFReferensi
Alatas F, Sutarna TH, Pratama MR, Lestari T. Pembentukan ko-amorf irbesartan-l-arginin dan dampaknya terhadap kelarutan dan laju disolusi irbesartan. Riset Informasi Kesehatan. 2020;9(2):98-106
Anggraeni D, Sangi MS, Fatimah F. Aktifitas Antiinflamasi Ekstrak Etanol Tepung Pelepah Aren (Arenga pinnanta). Chem Prog. 2020;13(2):123-127.
Arakawa T, Kita Y, Koyama AH. Solubility enhancement of gluten and organic compounds by arginine. Int J Pharm. 2008;355(1-2):220-223.
Bathe R, Latare B, Kalbhut R, Thak P, Bawane S. Formulation and Evaluation of Ketoprofen Emulgel. Int J Pharm Sciences. 2025;3(11):165-176
Beyer A, Radi L, Grohganz H, Löbmann K, Rades T, Leopold CS. Preparation and recrystallization behavior of spray-dried co-amorphous naproxen-indomethacin. Eur J Pharm Biopharm. 2016;104:72-81
Birmingham B & Buvanendran A. Practical management of pain 5th edition. Amsterdam : Elsevier. 2014
Dengale SJ, Grohganz H, Löbmann K, et al. Recent advances in co-amorphous drug formulations. Advanced Drug Delivery Reviews. 2016
DiPiro JT et al. Pharmacotherapy: A Pathophysiologic Edition. New Education. 2017 Approach, York: Tenth McGraw-Hill
Huang Y, Zhang Q, Wang J-R, Lin K-L, Mei X. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Pharm Dev Technol. 2016;7450:1–8.
Kementerian Kesehatan Republik Indonesia. Pedoman dan Standar Etik: Penelitian dan Pengembangan Kesehatan Nasional. Jakarta: Lembaga Penerbit Balitbangkes. 2021.
Lee T, Wang YW. Initial salt screening procedures for manufacturing ibuprofen. Drug Dev. Ind. Pharm. 2009;35:555–567.
Löbmann K, Strachan C, Grohganz H, Rades T, Korhonen O, Laitinen R. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. European Journal of Pharmaceutics and Biopharmaceutics. 2012;81:159-169
Luangtana-anan M, Luangtana-anan M, Nunthanid, et al. Potential of different salt forming agents on the formation of chitosan nanoparticles as carriers for protein drug delivery systems. J. Pharm. Investig. 2009;49:37–44.
Miles L, Hall J, Jenner B, Addis R, Hutchings S. Predicting rapid analgesic onset of ibuprofen salts compared with ibuprofen acid: Tlag, Tlow, Tmed,and a novel parameter. TCmaxRef. Curr. Med. Res. Opin. 2018;34:1483–1490
Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L.Solid state characterization and dissolution properties of naproxen– arginine–hydroxypropyl- β-cyclodextrin ternary system. Eur. J. Pharm. Biopharm. 2005;59:99–106.
Mura P, Maestrelli F, Cirri M. Ternary systems of naproxen with hydroxypropyl β- cyclodextrin and aminoacids. Int. J. Pharm. 2003;260:293– 302
Murakami T & Takano M. Intestinal efflux transporters and drug absorption. Expert Opinion on Drug Metabolism & Toxicology. 2008;4(7):923-939
Ojarinta R., Heikkinen AT, Sievänen E, Laitinen R.. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The abilityof amino acids to stabilize the supersaturated state of indomethacin. Eur.J. Pharm. Biopharm. 2017;112:85–95.
Patel D, Bertz R, Ren S, et al. A systematic review of gastric acid-reducing agentmediated drug-drug interaction with orally administrated medications. Clinical Pharmacokinetics. 2020;59:447-462
Polli J, Rekhi GS, Ausgburger LL, Shah VP. Methods to Compare Dissolution Profiles and a Rationale for Wide Dissolution Specifications for Metoprolol Tartrate Tablets. J Pharm Sci. 1997;86:690-700
Qi X, Zhang J, Wang W, Cao D. Solubility and stability of indomethacinin arginineassisted solubilization system. Pharm. Dev. Technol. 2013;18:852–855.
Sandri G, Bonferoni MC, Ferrari F, et al. The role of particle size in drug release and absorption. Particulate Products. 2014;19:323-341
USP Convention. United States Pharmacopeia 30 NF 25. United Sates of America : Pharmaceutical Press;2007
Wagner H, Spahn-Langguth A, Hanafy A, Koggel P, Langguth. Intestinal drug efflux: formulation and food effects. Advanced Drug Delivery Reviews. 2001:13-31
Ward RM, Kern SE, Lugo RA. Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics. Amsterdam : Elsevier. 2012
Whalen K. Lippincott Illustrated Reviews: Pharmacology 7 Th Edn . Philadephia: Wolters
Kluwer. 2019
DOI: https://doi.org/10.33024/jikk.v12i12.23675
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##
Pendidikan Dokter Universitas Malahayati Lampung

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
_JIKK_2024-2.pdf_.png)

1.png)
.png)
.png)
.png)
.jpg)



